DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Talampanel is an investigational drug.
There have been 11 clinical trials for Talampanel. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Motor Neuron Disease, Amyotrophic Lateral Sclerosis, and Parkinson Disease. The leading clinical trial sponsors are Teva Pharmaceutical Industries, National Cancer Institute (NCI), and National Institute of Neurological Disorders and Stroke (NINDS).
Recent Clinical Trials for Talampanel
|A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm||Cetero Research, San Antonio||Phase 1|
|A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm||Teva Pharmaceutical Industries||Phase 1|
|Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)||Teva Pharmaceutical Industries||Phase 2|